The UK’s MHRA has approved the first GLP-1 receptor agonist tablet for weight loss, offering a more convenient alternative to weekly injections. Semaglutide, branded as Wegovy, is now available in pill form for adults with obesity or those who are overweight with weight-related health conditions. Patients can transition directly from the weekly injection to the 25 mg daily tablet.
Australia’s High Court has concluded that Farm Transparency International maintains copyright over clandestinely acquired footage,…
Australia’s High Court has ordered a retrial in the case concerning the estate of a…
Gunjan showcased her exceptional talent by clinching the women's 48kg gold medal at the Dakar…
The Indian Air Force has launched indigenous artificial intelligence applications to improve operational efficiency and…
Post Content